Reported about 21 hours ago
Despite President Trump's exemption of pharmaceuticals from reciprocal tariffs, industry experts warn that the sector won't be entirely shielded from the negative effects of tariffs. Stephen Ezell from the ITIF highlights that while pharmaceuticals are currently safe, the supply chain and input costs for drug manufacturing may still face pressures, making it harder for U.S. pharmaceutical companies to compete globally.
Source: YAHOO